Medicare and GLP-1 Coverage: What to Know
A new Medicare program will make certain GLP-1 medications more affordable for eligible people with Medicare Part D. Here’s a quick look at what’s changing, who may qualify, and what to keep in mind.
What’s changing
Starting July 1, 2026, Medicare will begin the Medicare GLP-1 Bridge, a temporary CMS demonstration program that runs through December 31, 2027. The program is designed for eligible Medicare Part D beneficiaries using certain GLP-1 drugs for weight loss.
How it works
Eligible beneficiaries pay a flat $50 copay for a monthly supply of covered GLP-1 drugs through the Bridge. The program works outside the usual Medicare Part D coverage and payment flow, so the Part D deductible does not apply.
Who qualifies
To be eligible, beneficiaries generally need Medicare Part D coverage, receive prior authorization, and meet certain weight-related criteria. The Bridge is only for weight-loss use.
A few things to know
Covered drugs are limited. The $50 copay does not count toward true out-of-pocket costs and low-income subsidy assistance does not apply to the Bridge copay. Coupons and discount programs cannot be used for Bridge claims.
Where to learn more
People with Medicare can learn more and check whether they may qualify at Medicare.gov/glp1bridge. They can also call 1-800-MEDICARE (1-800-633-4227). TTY users can call 1-877-486-2048.
